Smarter scheduling may cut colonoscopy pain for High-Risk patients

NCT ID NCT07713953

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting This study
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jul 20, 2026 · Last updated Jul 21, 2026 · Updated 1 time

Summary

This trial tests whether a simple change in scheduling can reduce pain during unsedated colonoscopy. High-risk patients (based on factors like low weight, female sex, or prior surgery) are randomly assigned to either an expert endoscopist with over 5,000 procedures or a routine endoscopist. The goal is to see if expert care lowers the chance of moderate-to-severe pain, potentially making the procedure more tolerable for those who need it most.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Risk Score-Based Endoscopist Assignment
What this could lead to
If effective, this strategy could make unsedated colonoscopy less painful for high-risk patients, improving their experience and willingness to undergo future screenings.
What could go wrong
This is a small, early-stage trial with only 106 participants, so results may not apply broadly. The intervention depends on endoscopist expertise, which varies across hospitals.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 106 people

The number the study aims to enrol. It can still change while the study runs.

Expected to start

Jul 2026

An estimate. Start dates often move.

Expected to finish

Aug 2027

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 to 75 years

Sex

Anyone

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Age 18-75 years. * Outpatient or inpatient undergoing colonoscopy for medical screening, polyp surveillance, or polypectomy. * Pre-procedural risk score \>5 (based on the following scoring system: BMI \<19 \[5 points\], female sex \[1 point\], history of abdominal or pelvic surgery \[2 points\], constipation \[3 points\]). Exclusion Criteria: * Patients who have received sedation or analgesia prior to colonoscopy. * Patients unwilling to cooperate or unable to provide informed consent. * Incomplete intestinal obstruction. * Inflammatory bowel disease, multiple polyposis syndromes, or severe chronic cardiac or pulmonary disease. * Patients receiving anticoagulant therapy.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Colonoscopy pain are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    1 site. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • the First Affiliated Hospital of Ningbo University

    Ningbo, Zhejiang, 315000, China

More trials for these conditions

Other studies related to the condition(s) this trial covers.